Joshua P. Cohen, PhD

Fremanezumab for the Prevention of Chronic Migraine in Patients with Comorbid Depression: A Pooled Analysis of Phase 3 Studies

Objective: A pooled analysis evaluated reductions in migraine and headache days among chronic migraine (CM) patients with comorbid depression (scores ≥10 on the 9-item Patient Health Ques...

Dawn Buse ;

Xiaoping Ning ;

Ronghua Yang ;

Verena Ramirez-Campos ;

Richard Lipton , MD;

Joshua P. Cohen , PhD;

10/25/2020

All-cause Healthcare Resource Utilization and Costs Among Patients With Episodic or Chronic Migraine and Comorbid Depression and/or Anxiety

Objective: This real-world retrospective cohort study evaluated healthcare resource utilization (HCRU) and costs for adult patients with episodic migraine (EM) or chronic migraine (CM) an...

Guihua Zhang ;

Dawn Buse ;

Joshua P. Cohen , PhD;

Patricia Pozo-Rosich ;

Krishna Tangirala ;

Stephen Thompson ;

Lynda Krasenbaum ;

10/08/2020

Perspectives

Frameworks for Assessing the Value of Cancer Drugs: Purely an Academic Exercise?

08/02/2016

Joshua P. Cohen , PhD;

Abstract: As the cost of prescription drugs increases, payers and providers alike have attempted to determine the value of treatments for high-cost disease, including cancer. In this article, the authors discuss the...

...

08/02/2016

Journal of Clinical Pathways